# Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia

> **NCT02484248** · PHASE3 · RECRUITING · sponsor: **Craig A. Friesen, MD** · enrollment: 40 (estimated)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Ketotifen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02484248
- **Lead sponsor:** Craig A. Friesen, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-08
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484248, "Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02484248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*